Author:
Rane Rajesh,Prabhune Akshay,Kumar Dileep,Kumar Ajay,Sewlikar Madhur,Suryawanshi Mugdha,Satpute Bharat,Gawade Bapu,Sakat Sachin
Reference7 articles.
1. Preclinical toxicological assessment of levothyroxine and liothyronine Maillard impurities;Agarwal;Toxicol. Res.,2022
2. 715. The synthesis of thyroxine and related substances. Part V. A synthesis of L-thyroxine from L-tyrosine;Chalmers;J. Chem. Soc. (Resume ),1949
3. Impurities in new drug products;Guideline;Q3B (R2), Curr. step,2006
4. Guideline, I.H.T. Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Rockville, Maryland, US, 2011.
5. Chemistry and biology in the biosynthesis and action of thyroid hormones;Mondal;Angew. Chem. Int. Ed.,2016